GPAT BITS IN NOVEL DRUG DELIVERY SYSTEMS FOR B.PHARM STUDENTS

1. GPAT BITS
Novel drug delivery systems
2022
PREPARED BY
Dr. K.L.DEEPTHI, M.PHARM PH.D
Associate professor,
DEPARTMENT OF PHARMACEUTICS
Raghu college of pharmacy,
Vishakhapatnam.

2. Q1
MICROBALLOONS ARE:
A. hollow microspheres
B. microspheres with prolonged GRT
C. EUDRGIT containing microspheres
D. all of the above
2
DR K.L.DEEPTHI RCP

3. Q2
2. A non-ionic surfactant based multilamellar or
unilamellar vesicular structure
A. Microspheres
B. Liposome
C. Niosome
D. Nanoparticle
3
DR K.L.DEEPTHI RCP

4. Q3
3. Which of the following is a non- erodible
insert?
A. Ocusert
B. Collagen shield
C. NODS
D. SODI
4
DR K.L.DEEPTHI RCP

5. Q4
4. The polymer used in “Lacriset”
A. Hydoxy ethyl cellulose
B. Hydoxy Methyl cellulose
C. Methyl cellulose
D. Hydroxy propyl cellulose
5
DR K.L.DEEPTHI RCP

6. Q5
List out abiodegradable polymer
A. Polylactides (PLA)
B. Polyglycolides (PGA)
C. Poly(lactide-co-glycolides) (PLGA)
D. All of the Above
6
DR K.L.DEEPTHI RCP

7. Q6
Achievement of zero order is easy for:
A. Matrix Systems
B. Reservoir systems
C. none of the above
D. both a & B
7
DR K.L.DEEPTHI RCP

8. Q7
In diffusion and dissolution controlled systems,
the Release rate is dependent on
A. surface area
B. diffusion coefficient of drug though pore in
coating
C. diffusion path length
D. all of the above
8
DR K.L.DEEPTHI RCP

9. Q8
Materials Used as Retardants in Matrix Tablet
Formulations
A. Polyethylene
B. Polyvinyl acetate
C. Polyvinyl chloride
D. All of the above
9
DR K.L.DEEPTHI RCP

10. Q9
A Polymer used for colonic systems is
A. carboxymethyl cellulose
B. cellulose acetate phthalate
C. gelatin
D. acacia
10
DR K.L.DEEPTHI RCP

11. Q 10
Excipient to increase density of GRDDS is
A. zinc oxide
B. barium sulfate
C.titanium dioxide
D. All of the above
11
DR K.L.DEEPTHI RCP

12. Q 11
One method to prepare liposomes is
A. pan coating
B. filtration
C. ether injection
D. precipitation
12
DR K.L.DEEPTHI RCP

13. Q12
Sodium taurocholate used as penetration
enhancer is
• A. A Surfactant
• B. Fatty acid with surfactant property
• C. Bile salt
• D. All of the above
13
DR K.L.DEEPTHI RCP

14. Q13
The IMPLANT oncogel which is used in
oesophagal cancer contains ------------ polymer
• A. silicon
• B. methacrylate
• C. PLGA-PEG-PLGA
• D. all of the above
14
DR K.L.DEEPTHI RCP

15. Q 14
BASIC COMPONENTS OFA TRANSDERMAL
PATCH:
A. polymer matrix
B. backing membrane
C. adhesive
D. all of the above
15
DR K.L.DEEPTHI RCP

16. Q15
Stealth liposomes
A. PEG containing
B. are sterically stabilized
C. only A
D. both A and B
16
DR K.L.DEEPTHI RCP

17. Q16
Which of the following is theory of mucoadhesion
A. Adsorption
B. DISSOUTION
C. ABSORPTION
D.HIXSON
17
DR K.L.DEEPTHI RCP

18. Q17
The metered dose inhalers has the advantage:
A. high reliability and stability
B. high reliability and accurate performance
C. low reliability and stability
D. low reliability and low stability
18
DR K.L.DEEPTHI RCP

19. Q18
Collagen Shields are:
A. MONOLITHIC SYSTEMS
B. IUD’S
C. OCCUSERTS
D. TRANSDERMAL PATCHES
19
DR K.L.DEEPTHI RCP

20. Q19
Cyclodextrins is useful to increase -----of drug in
eye:
A. solubility
B. permeability
C. Contactability
D. all of the above
20
DR K.L.DEEPTHI RCP

21. Q20
MICROBALLOONS ARE:
A. hollow microspheres
B. microspheres with prolonged GRT
C. EUDRGIT containing microspheres
D. all of the above
21
DR K.L.DEEPTHI RCP

22. Q2I
1.Drugs Unsuitable for controlled release.
A.penicillin G,
B.Furosemide
C.Diazepam
D. All of the above
22
DR K.L.DEEPTHI RCP

23. Q22
Mucocilliary clearance is
A. A barrier to nasal absorption
B. Not a barrier to nasal absorption
C. It is protective in function
D. It is a barrier to nasal absorption but also
protective in function
23
DR K.L.DEEPTHI RCP